|
|
|
Volumn 50, Issue 5, 2004, Pages 602-604
|
|
Use of fludarabin in conjunction with other cytostatics in therapy of non-hodgkin's disease resistant to standard chemotherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYTOSTATIC AGENT;
FLUDARABINE;
MITOXANTRONE;
PREDNISOLONE;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
VIDARABINE;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERANCE;
HUMAN;
MORPHOLOGY;
NONHODGKIN LYMPHOMA;
RECURRENCE RISK;
REMISSION;
STATISTICAL SIGNIFICANCE;
ADULT;
AGED;
DRUG ADMINISTRATION;
FEMALE;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
MITOXANTRONE;
PREDNISOLONE;
TREATMENT OUTCOME;
VIDARABINE;
|
|
EID: 13844316457
PISSN: 05073758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (10)
|
